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Acute myocardial infarction in a patient  
with chronic renal failure and endocarditis
Ostry zawał serca u chorego z przewlekłą niewydolnością nerek i zapaleniem wsierdzia
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A b s t r a c t
We report a case of a 55 year-old female with chronic renal failure who received routine haemodialysis and suffered from 
acute myocardial infarction of inferior wall. Based on coronary angiogram, transoesophageal echocardiography, and autopsy, 
coronary embolisation with vegetations in the course of infective endocarditis was identified as a rare cause of ST-segment 
elevation myocardial infarction.
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Systemic embolisation and, in particular, central nervous 
system embolisation is a frequent complication of infective endo-
carditis. Embolised vegetations have been reported also as a rare 
cause of ST-segment elevation myocardial infarction (STEMI) [1].
A 55 year-old female, with chronic renal failure and ar-
terial hypertension, was admitted to the nephrology unit for 
routine haemodialysis (she had been receiving haemodialysis 
for about five years). During dialysis, a sudden drop of blood 
pressure was noticed and she lost consciousness. ST-segment 
elevation in II, III, aVF leads was noted in the electrocardio-
gram. The patient was intubated, mechanically ventilated, 
and scheduled for urgent coronary angiography as the di-
agnosis of acute coronary syndrome was established. She 
was pretreated with 325 mg of acetylsalicylic acid, 600 mg 
of clopidogrel and 5,000 U of unfractionated heparin. On 
admission to the cath lab, she remained unconscious with 
respiratory support, with blood pressure of 90/50 mm Hg, 
despite the infusion of vasopressors. Physical examination 
revealed 4/6 systolic murmur with its maximum at the Erb’s 
point, so a transthoracic echocardiography was performed 
showing akinesia of the inferior wall, hyperkinesia of other 
left ventricle walls, with ventricular ejection fraction of 75%. 
Doppler examination revealed a moderate to severe mitral 
regurgitation and moderate tricuspid insufficiency with the 
accompanying high-grade pulmonary hypertension (systolic 
pulmonary artery pressure [SPAP] of 60 mm Hg). After ob-
taining arterial and venous accesses, an intra-aortic balloon 
pump (rate 1:1) was inserted and a coronary angiography 
was performed. Only minor atherosclerotic lesions in the left 
coronary artery (Fig. 1A) and an occlusion of the left ventricular 
branch arising from the right coronary artery (Fig. 1B) were 
noted. Based on clinical status, acute mitral regurgitation due 
to papillary muscle rupture was suspected. Percutaneous coro-
nary intervention of the occluded infarct-related artery was 
attempted using Launcher (Medtronic Vascular, USA) 6 French 
right Judkins 4.0 guiding catheter and soft 0.014-inch BMW 
(Abbott Vascular, USA) guidewire. The wire could not pass the 
occlusion site even supported by the balloon catheter. The 
following wires were used: Whisper MS, Pilot 50, Pilot 150 (all 
from Abbott Vascular, USA), without success (Fig. 1C). Due 
to no progress and the prolonged duration of the angioplasty, 
the procedure was stopped. Suspecting a pulmonary embo-
lism (drop in blood pressure and high SPAP), a pulmonary 
arterial angiography was performed; this did not reveal any 
abnormalities. The patient was still unconscious, mechani-
cally ventilated, with the infusion of vasopressors and systolic 
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blood pressure of about 90 mm Hg. She was transferred to 
the coronary care unit. Due to a discrepancy between clinical 
presentations (cardiogenic shock, acute mitral regurgitation) 
and coronary angiography results (relatively small vessel oc-
clusion) a bedside transoesophageal echocardiography (TEE) 
was performed to search for a potential, non-ischaemic, cause 
of mitral regurgitation. TEE revealed massive mobile vegeta-
tions on mitral leaflets (Fig. 2A) and perforation of posterior 
leaflet with severe mitral regurgitation (Fig. 2B). The patient 
was urgently reported to the cardiac surgery unit, but she was 
scheduled for conservative treatment. Blood samples were 
taken for microbiological tests for aerobic and anaerobic 
bacteria. Empirical antibiotic therapy with ceftriaxone and 
a reduced dose of metronidazole were started. Peak levels 
of CK, CK-MB, and troponin I were 1,120 U/L, 94 U/L, and 
4.36 µg/L, respectively. Microbiological tests were negative. 
On the third day after admission, the subject died due to 
acute heart failure. The presence of vegetation on the mitral 
valve, perforation of the posterior mitral leaflet, and the left 
ventricular branch occlusion caused by embolic material from 
the vegetation was confirmed by autopsy. 
STEMI resulting from an infective endocarditis is a rare 
clinical entity [1, 2]. The left anterior descending artery is the 
most common site of coronary embolisation by vegetations, 
originating frequently from the anterior mitral leaflet [3–5]. 
The second possibility is an occlusion of coronary artery ostium 
by vegetation arising from the aortic valve. In our case, the left 
ventricle branch of the right coronary artery was occluded. 
There is no clear evidence for the treatment of STEMI caused 
by endocarditis. Anticoagulation does not prevent embolisa-
Figure 1. Primary angioplasty in patient with ST-segment elevation myocardial infarction caused by coronary embolisation during 
the course of infective endocarditis; A. Coronary angiography in the anteroposterior cranial view showing mild diffuse disease 
of the left coronary artery; B. Coronary angiography in the left anterior oblique view showing mild diffuse disease of the right 
coronary artery and an occlusion of the left ventricular branch (arrow); C. Final coronary angiography after failed angioplasty of 
the left ventricular branch (arrow)
Figure 2. Transoesophageal echocardiogram (TEE) in patient with ST-segment elevation myocardial infarction caused by coro-
nary embolisation during the course of infective endocarditis; A. Grey-scale TEE in mid-oesophageal two-chamber view with 
large vegetation on the posterior mitral leaflet (arrow); B. Colour Doppler TEE, mid-oesophageal two-chamber view with severe 
paravalvular leak (arrow)
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tion during the course of infective endocarditis, and addition-
ally may raise the bleeding risk. Also, the use of fibrinolytic 
therapy in STEMI caused by endocarditis may increase the 
intracranial bleeding risk and may be even contraindicated [3]. 
Primary angioplasty is thought to be relatively safe, although 
no data on the safety and efficacy of percutaneous treatment 
in patients with infective endocarditis is available. Balloon 
inflation at the site of the occlusion may result in displacement 
of the vegetation and has relatively poor outcomes regarding 
vessel patency. A stent implantation might be helpful, but the 
risk of stent deployment during bacteremia should be taken 
into account before its use [6, 7]. According to the European 
Society of Cardiology Guidelines from 2009 [8], infective 
endocarditis complicated by acute cardiac failure is a major 
indication for urgent surgery. However, due to STEMI compli-
cated by cardiogenic shock and unclear status of bacteremia 
at the time of presentation, the subject was scheduled for 
initial conservative treatment. 
This case report serves as a reminder that infective en-
docarditis can be a rare cause of acute myocardial infarction. 
Importantly, haemodialysed subjects are especially prone to 
infective endocarditis. Occluded coronary artery may be 
treated mechanically, with coronary angioplasty. In a patient in 
cardiogenic shock and where there is a discrepancy between 
clinical findings and symptoms, a TEE is worth performing in 
order to exclude other causes. Such a subject should be also 
immediately referred to the cardiosurgery department.
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